Armand M G Jaminon
Overview
Explore the profile of Armand M G Jaminon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Panagiotou N, McGuinness D, Jaminon A, Mees B, Selman C, Schurgers L, et al.
Cells
. 2023 Jul;
12(13).
PMID: 37443741
Extracellular vesicles (EVs), comprising microvesicles (MVs) and exosomes (Exos), are membranous vesicles secreted by cells which mediate the repair of cellular and tissue damage via paracrine mechanisms. The action of...
2.
Jaminon A, Akbulut A, Rapp N, Reutelingsperger C, Schurgers L
Methods Mol Biol
. 2023 Jul;
2664:317-331.
PMID: 37423997
Vascular calcification is an active pathological process, characterised by cellular dysregulation and subsequent changes to the extracellular environment. In vivo detection of vascular calcification is only possible late stage via...
3.
van Gorp R, Baaten C, Habibi A, Jaminon A, Peeters F, Leenders P, et al.
Eur Heart J Open
. 2022 Aug;
1(2):oeab017.
PMID: 35919270
Aims: Vascular calcification is a hallmark of atherosclerotic burden and can predict the cardiovascular outcome. Vitamin K antagonists (VKA) are widely used anticoagulant drugs to treat patients at risk of...
4.
Jaminon A, Rapp N, Akbulut A, Dzhanaev R, Reutelingsperger C, Jahnen-Dechent W, et al.
J Vis Exp
. 2022 Jun;
(184).
PMID: 35723489
Vascular calcification involves a series of degenerative pathologies, including inflammation, changes to cellular phenotype, cell death, and the absence of calcification inhibitors, that concomitantly lead to a loss of vessel...
5.
Skenteris N, Seime T, Witasp A, Karlof E, Wasilewski G, Heuschkel M, et al.
Clin Transl Med
. 2022 Feb;
12(2):e682.
PMID: 35184400
Rationale: Vascular calcification is a prominent feature of late-stage diabetes, renal and cardiovascular disease (CVD), and has been linked to adverse events. Recent studies in patients reported that plasma levels...
6.
van der Laan K, Reesink K, van der Bruggen M, Jaminon A, Schurgers L, Megens R, et al.
Front Physiol
. 2022 Jan;
12:814434.
PMID: 35095571
Accurate information on vascular smooth muscle cell (VSMC) content, orientation, and distribution in blood vessels is indispensable to increase understanding of arterial remodeling and to improve modeling of vascular biomechanics....
7.
Jaminon A, Akbulut A, Rapp N, Kramann R, Biessen E, Temmerman L, et al.
Cells
. 2021 Aug;
10(8).
PMID: 34440866
Background: Vascular calcification is an active process that increases cardiovascular disease (CVD) risk. There is still no consensus on an appropriate biomarker for vascular calcification. We reasoned that the biomarker...
8.
Dai L, Li L, Erlandsson H, Jaminon A, Qureshi A, Ripsweden J, et al.
PLoS One
. 2021 Feb;
16(2):e0247623.
PMID: 33626087
Patients with chronic kidney disease (CKD) suffer from vitamin K deficiency and are at high risk of vascular calcification (VC) and premature death. We investigated the association of functional vitamin...
9.
Jaminon A, Dai L, Qureshi A, Evenepoel P, Ripsweden J, Soderberg M, et al.
Sci Rep
. 2020 Apr;
10(1):6586.
PMID: 32313061
Matrix Gla protein (MGP) is a potent inhibitor of vascular calcification (VC) and requires carboxylation by vitamin K to exert calcification inhibition. Chronic kidney disease (CKD) patients undergo early vascular...
10.
Posthuma J, Posma J, Van Oerle R, Leenders P, van Gorp R, Jaminon A, et al.
Sci Rep
. 2019 Mar;
9(1):3909.
PMID: 30846818
Atherosclerosis is a progressive inflammatory vascular disorder, complicated by plaque rupture and subsequently atherothrombosis. In vitro studies indicate that key clotting proteases, such as factor Xa (FXa), can promote atherosclerosis,...